Nuvation Bio CSO sells 100K shares after option exercise
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nuvation Bio Inc. (NUVB) reported that Chief Scientific Officer Gary Hattersley exercised options for 100,000 shares of Class A Common Stock at an exercise price of $1.87 per share and sold 100,000 shares on the same date at a weighted-average price of $7.0924, under a Rule 10b5-1 trading plan dated December 4, 2025. Following the option exercise, he held 400,000 stock options directly, with the option expiring on February 27, 2034 and vesting 25% after one year from February 29, 2024 and monthly over the next 36 months, subject to continued service.
Insider Trade Summary 10b5-1
Exercise and Sale: 100,000 shares ($522K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Hattersley Gary
Role
CHIEF SCIENTIFIC OFFICER
Sold
100,000 shs ($709K)
Approx. gross sale proceeds
$709K
Approx. exercise cost
$187K
Approx. pre-tax spread
$522K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F3 | 100,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 100,000 | $1.87 | $187K |
| Sale | Class A Common Stock F1, F2 | 100,000 | $7.0924 | $709K |
Holdings After Transaction:
Stock Option (Right to Buy) — 400,000 contracts (Direct);
Class A Common Stock — 0 shares (Direct)
Footnotes (3)
- F1. Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.
- F2. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.02 to $7.21. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F3. Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Key Figures
Shares sold: 100,000 shares
Weighted-average sale price: $7.0924 per share
Option exercise size: 100,000 shares
+4 more
7 metrics
Shares sold
100,000 shares
Class A Common Stock sold on August 19, 2026
Weighted-average sale price
$7.0924 per share
Sales of 100,000 shares on August 19, 2026; prices ranged $7.02–$7.21
Option exercise size
100,000 shares
Stock Option (Right to Buy) exercised into Class A Common Stock
Option exercise price
$1.87 per share
Conversion or exercise price for 100,000 underlying shares
Options held after transaction
400,000 stock options
Total Stock Option (Right to Buy) shares following the exercise
Option expiration date
February 27, 2034
Expiration date of the exercised stock option grant
10b5-1 plan date
December 4, 2025
Date of Rule 10b5-1 trading plan governing the share sale
Key Terms
Rule 10b5-1 plan, Stock Option (Right to Buy, weighted-average sales price, Class A Common Stock, +1 more
5 terms
Rule 10b5-1 plan regulatory
"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Stock Option (Right to Buy financial
"security_title: "Stock Option (Right to Buy)""
weighted-average sales price financial
"Price reported is a weighted-average sales price."
Class A Common Stock financial
"underlying_security_title: "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
continuous service other
"subject to Reporting Person's continuous service on each such vesting date."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did NUVB Chief Scientific Officer Gary Hattersley report?
Gary Hattersley exercised options for 100,000 shares of NUVB Class A Common Stock at $1.87 per share and sold 100,000 shares on the same date at a weighted-average price of $7.0924, in a sequence of option exercise followed by share sale.
What is the size and strike price of the NUVB stock option exercised by the CSO?
The CSO exercised a stock option for 100,000 underlying shares of Class A Common Stock at an exercise price of $1.87 per share. After this transaction, the filing shows 400,000 stock options held directly following the transaction.
When does the NUVB stock option held by the CSO expire and how does it vest?
The stock option expires on February 27, 2034. A footnote states it vests 25% on the one-year anniversary of February 29, 2024, with the remainder vesting monthly over the following 36 months, subject to the CSO’s continuous service on each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
